Real-time enrollment status for this lupus nephritis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:30 PM UTC
| NCT Number | NCT06711887 |
| Recruiting Status | Recruiting |
| Condition | Lupus Nephritis |
| Phase | PHASE3 |
| Target Enrollment | 348 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT06711887 is currently recruiting participants. This phase3 study for lupus nephritis is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06711887 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06711887 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.